Kirsehir Ahi Evran Universitesi

ahievran.edu.tr

Total trials

125

Active

50

Phase 3

0

Total enrollment

9,394

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 0 of 0 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal

Next readouts

No upcoming readouts found.

Top conditions

  • Neck Pain7
  • Low Back Pain5
  • Pain5
  • Rheumatoid Arthritis5
  • Chronic Neck Pain4
  • Cerebral Palsy4
  • Carpal Tunnel Syndrome (CTS)3
  • Fibromyalgia3

Frequently asked questions about Kirsehir Ahi Evran Universitesi

How many clinical trials does Kirsehir Ahi Evran Universitesi have on ClinicalTrials.gov?
Kirsehir Ahi Evran Universitesi is listed as the lead sponsor on 125 clinical trials in ClinicalTrials.gov, 50 of which are currently active (recruiting, enrolling, or ongoing).
How many of Kirsehir Ahi Evran Universitesi's trials are in Phase 3?
0 of Kirsehir Ahi Evran Universitesi's trials are in Phase 3.
What therapeutic areas does Kirsehir Ahi Evran Universitesi focus on?
Kirsehir Ahi Evran Universitesi's most-studied conditions on ClinicalTrials.gov are Neck Pain, Low Back Pain, Pain, Rheumatoid Arthritis, Chronic Neck Pain.